"Unnamed: 0","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-198933","R-HSA-198933","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell","24/194","134/10891",9.21873087516787e-18,3.87186696757051e-15,3.18288813374217e-15,"B2M/CD160/CD300A/CD300C/CD300E/CD300LF/COLEC12/CRTAM/HLA-E/KLRB1/KLRK1/LAIR1/LILRB4/NCR1/NCR3LG1/NECTIN2/NPDC1/OSCAR/PILRA/PILRB/SIGLEC10/SIGLEC8/TREM2/VCAM1",24
"R-HSA-5669034","R-HSA-5669034","TNFs bind their physiological receptors","10/194","29/10891",3.80724628741868e-11,7.99521720357924e-09,6.57250938038594e-09,"CD27/EDA2R/TNFRSF13B/TNFRSF14/TNFRSF1A/TNFRSF1B/TNFRSF4/TNFRSF6B/TNFRSF8/TNFRSF9",10
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","16/194","125/10891",6.29510165007692e-10,7.22648659392234e-08,5.94057043309907e-08,"CHRDL1/CKAP4/CSF1/CST3/FGF23/FSTL3/HRC/IGFBP4/IGFBP6/IGFBP7/LGALS1/PENK/SCG2/SHISA5/TGOLN2/TIMP1",16
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","15/194","108/10891",6.88236818468795e-10,7.22648659392234e-08,5.94057043309907e-08,"CHRDL1/CKAP4/CSF1/CST3/FGF23/FSTL3/HRC/IGFBP4/IGFBP7/LGALS1/PENK/SCG2/SHISA5/TGOLN2/TIMP1",15
"R-HSA-5668541","R-HSA-5668541","TNFR2 non-canonical NF-kB pathway","14/194","102/10891",3.05000432601665e-09,2.56200363385399e-07,2.10610825038623e-07,"CD27/EDA2R/LTBR/TNF/TNFRSF11A/TNFRSF12A/TNFRSF13B/TNFRSF14/TNFRSF1A/TNFRSF1B/TNFRSF4/TNFRSF6B/TNFRSF8/TNFRSF9",14
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","28/194","482/10891",2.90729959931085e-08,2.0351097195176e-06,1.67297240100695e-06,"ADA2/ADAM8/B2M/B4GALT1/BST2/CANT1/CD300A/CD55/CD59/CFD/CHI3L1/CKAP4/CLEC4D/CST3/CTSZ/GM2A/LAIR1/LCN2/NFASC/NPC2/OSCAR/PIGR/PLAUR/PSAP/PTPRN2/RNASET2/SIRPB1/TNFRSF1B",28
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","8/194","47/10891",1.52173874829803e-06,9.13043248978815e-05,7.50571893897372e-05,"CD80/CSF1/IL10RB/IL12B/TIMP1/TNF/TNFRSF1A/TNFRSF1B",8
"R-HSA-9694614","R-HSA-9694614","Attachment and Entry","5/194","19/10891",1.61660080947777e-05,0.00084871542497583,0.00069769087566935,"AGRN/CTSL/HAVCR1/HSPG2/SDC1",5
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","17/194","300/10891",2.52188589622284e-05,0.00117688008490399,0.00096746032042232,"ADAM12/ADAM8/ADAM9/AGRN/BSG/COL18A1/COL6A3/CTSL/EFEMP1/ELN/FBLN2/HSPG2/JAM2/MMP7/SDC1/TIMP1/VCAM1",17
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","6/194","45/10891",0.00013507116385446,0.0056729888818877,0.00466350965729114,"B2M/CD300E/HLA-E/KLRK1/SIRPB1/TREM2",6
"R-HSA-1474228","R-HSA-1474228","Degradation of the extracellular matrix","10/194","140/10891",0.00019687368472339,0.00751699523489316,0.00617938455399739,"ADAM8/ADAM9/BSG/COL18A1/COL6A3/CTSL/ELN/HSPG2/MMP7/TIMP1",10
"R-HSA-5694530","R-HSA-5694530","Cargo concentration in the ER","5/194","33/10891",0.00026946410506552,0.00883126394851519,0.0072597859025388,"AREG/CD59/CTSZ/FOLR1/TGFA",5
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","6/194","51/10891",0.00027334864602547,0.00883126394851519,0.0072597859025388,"EFNA1/EFNA4/EPHA1/EPHA2/EPHB4/EPHB6",6
"R-HSA-9772572","R-HSA-9772572","Early SARS-CoV-2 Infection Events","5/194","38/10891",0.00053026145008955,0.0150904029229157,0.0124051432549282,"AGRN/CTSL/HAVCR1/HSPG2/SDC1",5
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","9/194","137/10891",0.00075576843706329,0.0150904029229157,0.0124051432549282,"BSG/CD48/CD74/ESAM/JAM2/SDC1/THBD/TNFRSF10A/TNFRSF10B",9
"R-HSA-3560782","R-HSA-3560782","Diseases associated with glycosaminoglycan metabolism","5/194","41/10891",0.00075822505115086,0.0150904029229157,0.0124051432549282,"AGRN/B4GALT1/HSPG2/OGN/SDC1",5
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","19/194","473/10891",0.00077530447515101,0.0150904029229157,0.0124051432549282,"CD4/CD80/CSF1/HAVCR2/IL10RB/IL12B/IL15RA/IL18BP/IL18R1/IL2RA/IL4R/LCN2/LGALS9/SDC1/TIMP1/TNF/TNFRSF1A/TNFRSF1B/VCAM1",19
"R-HSA-216083","R-HSA-216083","Integrin cell surface interactions","7/194","85/10891",0.00078028510689077,0.0150904029229157,0.0124051432549282,"AGRN/BSG/COL18A1/COL6A3/HSPG2/JAM2/VCAM1",7
"R-HSA-449836","R-HSA-449836","Other interleukin signaling","4/194","24/10891",0.00078437281730424,0.0150904029229157,0.0124051432549282,"CD4/CSF1/IL10RB/SDC1",4
"R-HSA-1236977","R-HSA-1236977","Endosomal/Vacuolar pathway","3/194","11/10891",0.00082637920768347,0.0150904029229157,0.0124051432549282,"B2M/CTSL/HLA-E",3
"R-HSA-3371378","R-HSA-3371378","Regulation by c-FLIP","3/194","11/10891",0.00082637920768347,0.0150904029229157,0.0124051432549282,"FAS/TNFRSF10A/TNFRSF10B",3
"R-HSA-5218900","R-HSA-5218900","CASP8 activity is inhibited","3/194","11/10891",0.00082637920768347,0.0150904029229157,0.0124051432549282,"FAS/TNFRSF10A/TNFRSF10B",3
"R-HSA-69416","R-HSA-69416","Dimerization of procaspase-8","3/194","11/10891",0.00082637920768347,0.0150904029229157,0.0124051432549282,"FAS/TNFRSF10A/TNFRSF10B",3
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","9/194","143/10891",0.00102634805877974,0.0179610910286455,0.0147650071613928,"ADAMTS15/AGRN/B4GALT1/HSPG2/OGN/SDC1/SPON1/SPON2/THBS2",9
"R-HSA-6803211","R-HSA-6803211","TP53 Regulates Transcription of Death Receptors and Ligands","3/194","12/10891",0.00108743817817899,0.0182689613934071,0.0150180935765351,"FAS/TNFRSF10A/TNFRSF10B",3
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","6/194","69/10891",0.00139636086948192,0.0225565986608618,0.0185427678214603,"CD28/CD4/CD80/PDCD1/PDCD1LG2/TNFRSF14",6
"R-HSA-3656237","R-HSA-3656237","Defective EXT2 causes exostoses 2","3/194","14/10891",0.00175255149371694,0.0260566258403787,0.021419983146978,"AGRN/HSPG2/SDC1",3
"R-HSA-3656253","R-HSA-3656253","Defective EXT1 causes exostoses 1, TRPS2 and CHDS","3/194","14/10891",0.00175255149371694,0.0260566258403787,0.021419983146978,"AGRN/HSPG2/SDC1",3
"R-HSA-2424491","R-HSA-2424491","DAP12 signaling","4/194","30/10891",0.00186118756002705,0.0260566258403787,0.021419983146978,"B2M/HLA-E/KLRK1/TREM2",4
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","4/194","30/10891",0.00186118756002705,0.0260566258403787,0.021419983146978,"EFNA1/EFNA4/EPHA1/EPHA2",4
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","6/194","78/10891",0.00262240339568635,0.0355293363286538,0.029207073473179,"AREG/CD28/CD80/FGF23/FGFR2/TGFA",6
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","7/194","108/10891",0.00313030982303442,0.0400619111750389,0.0329330999133152,"IL12B/IL4R/LCN2/TIMP1/TNF/TNFRSF1B/VCAM1",7
"R-HSA-140534","R-HSA-140534","Caspase activation via Death Receptors in the presence of ligand","3/194","17/10891",0.00314772159232448,0.0400619111750389,0.0329330999133152,"FAS/TNFRSF10A/TNFRSF10B",3
"R-HSA-5676594","R-HSA-5676594","TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway","3/194","18/10891",0.00372815038188049,0.0460536223644061,0.0378586168810155,"LTBR/TNFRSF11A/TNFRSF12A",3
"R-HSA-5083635","R-HSA-5083635","Defective B3GALTL causes PpS","4/194","37/10891",0.00407130926511994,0.0488557111814392,0.0401620883897546,"ADAMTS15/SPON1/SPON2/THBS2",4
